Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression

Abstract

This study exemplifies the prognostic value of a patient-derived organoid-based biomarker within a clinical setting, which is especially important for people carrying rare <i>CFTR</i> mutations with unclear clinical consequences.